Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Merck's Cholesterol-Lowering Drug Reduces Heart Problems

November 18, 2014 10:22 am | News | Comments

Merck, known as MSD outside the United States and Canada, announced that the investigational IMPROVE-IT study met its primary and all secondary composite efficacy endpoints.  Read more...

TOPICS:

Preferred Drug Regimen for Preventing Mother-to-Child HIV Transmission

November 18, 2014 10:14 am | News | Comments

For HIV-infected women in good immune health, taking a three-drug regimen during pregnancy prevents mother-to-child HIV transmission more effectively than taking one drug during pregnancy, another during labor and two more after giving birth, an international clinical trial has found. Read more...

TOPICS:

Novartis' Drug Could Change Course of Heart Failure for Patients

November 18, 2014 9:57 am | News | Comments

New data on Novartis' investigational medicine, LCZ696, for patients with heart failure with reduced ejection fraction (HFrEF) shows it has the potential to change the course of the disease for patients. Read more...

TOPICS:
Advertisement

Journal Watch: Top 100 Cited Papers of All Time

November 18, 2014 9:52 am | by Drug Discovery & Development Staff | Articles | Comments

In honor of the SCI’s 50th anniversary, the journal Nature asked Thomson Reuters for the 100 most highly cited papers of all time.  Read more...                                  

TOPICS:

Actavis to Buy Allergan for $66B

November 17, 2014 2:34 pm | by Tom Murphy - AP Business Writer | News | Comments

Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally end a months-long takeover push from Valeant Pharmaceuticals. Read more...                

TOPICS:

Roche Announces FDA Approval of Ovarian Cancer Treatment

November 17, 2014 1:30 pm | News | Comments

The FDA approves Roche's ovarian cancer treatment. Read more...                                 

TOPICS:

Method Developed for Detecting Tumor-Causing Mutations in Saliva

November 17, 2014 1:18 pm | News | Comments

Current methods to screen for lung cancer mutations in plasma or blood are complicated, technique-dependent and not readily available. Read more...                   

TOPICS:

Statins Reverse Learning Disabilities Caused By Genetic Disorder

November 17, 2014 1:08 pm | News | Comments

Scientists have discovered that statins reverse the learning disabilities caused by a genetic disorder. Read more...                        

TOPICS:
Advertisement

Genzyme's MS Drug Gains FDA Approval

November 17, 2014 12:56 pm | News | Comments

The FDA approved Genzyme's new drug for the treatment of multiple sclerosis. Read more...                             

TOPICS:

DEA Agents Raid NFL Medical Staffs After Games

November 17, 2014 12:39 pm | by Jim Litke - AP Sports Writer | News | Comments

The DEA investigation comes during a turbulent time for the NFL. Read more...                               

TOPICS:

Study Lifts Cloud Over Heart Drugs

November 17, 2014 12:25 pm | by Marilynn Marchione - AP Chief Medical Writer | News | Comments

A major study lifts a cloud around blockbuster drugs for lowering cholesterol. Read more...                             

TOPICS:

Eisai's Antiepileptic Treatment Receives Russian Approval

November 17, 2014 10:34 am | News | Comments

Eisai Pharmaceuticals announces Russian approval of antiepileptic treatment. Read more...                             

TOPICS:

Nebraska Hospital: Surgeon With Ebola Has Died

November 17, 2014 10:03 am | by Nelson Lampe - Associated Press | News | Comments

A surgeon who contracted Ebola in his native Sierra Leone died Monday while being treated in a biocontainment unit at a Nebraska hospital. Read more...                   

TOPICS:

A New Approach to Fighting Leukemia

November 17, 2014 9:50 am | News | Comments

Leukemia treatments are often limited by the fact that the cancer cells can adapt to resist drugs. Read more...                         

TOPICS:

Beta Blockers Could Benefit Patients With HFPEF

November 17, 2014 9:29 am | News | Comments

A new study suggests that beta blockers may benefit patients suffering from a relatively unknown form of heart failure. Read more...                      

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading